Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders. Evolent’s Class A common stock is listed on the New York Stock Exchange under the symbol “EVH.”
Based in Arlington, Virginia, Evolent Health partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent Health helps physicians and health systems achieve superior quality and cost results. Evolent Health's approach breaks down barriers, aligns incentives and powers a new model of care delivery, resulting in meaningful alignment between providers, payers, physicians and patients.
The Davis Polk corporate team included partner Richard D. Truesdell Jr. and associates Yasin Keshvargar and John H. Runne. The tax team included partner Mary Conway and associates Patrick E. Sigmon and Elina Khodorkovsky. Partner Pritesh P. Shah and associate Gregory R. Baden provided intellectual property and technology advice. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.